FDA Reports Link Energy Drinks and Stimulants to Increased Cardiac Arrest Risk
Preliminary research to be presented at the American Heart Association’s Scientific Sessions 2026 indicates that caffeinated energy drinks and stimulant supplements are disproportionately represented in FDA reports of serious cardiovascular events. The study, which analyzed 28,345 adverse-event reports to the FDA from 2017 to 2025, found that cardiac arrest was reported approximately 11 times more often in connection with caffeine- and stimulant-containing products compared to products without these ingredients.


